Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
Authors:
Open Access
- 22 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 919559
Abstract
Family with sequence similarity 83 (FAM83) is a newly identified family of oncogenes whose members play important roles in signaling and cancer progression. However, a thorough understanding of the FAM83 family in tumors is still lacking. Here, we performed a comprehensive analysis of the expression levels of the FAM83 family across cancers and patient prognoses using bioinformatics methods. We found that the expression levels of FAM83 family genes were upregulated in most tumors, and importantly, high expression levels of FAM83 family genes were related to poor prognosis in most tumors. In addition, we analyzed the relationship of FAM83 family genes with immune subtypes and the tumor microenvironment (TME). The results showed that FAM83 family genes were significantly associated with immune infiltrative subtypes and to varying degrees with the level of stromal cell infiltration and tumor stem cells. Finally, our study also showed the relationship between FAM83 family genes and drug sensitivity. Therefore, this pan-cancer analysis demonstrates the critical role of FAM83 family genes in tumor development and provides new clues for therapeutic strategies for cancer.Keywords
This publication has 46 references indexed in Scilit:
- FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinomaInternational Journal of Oncology, 2015
- Conserved Oncogenic Behavior of the FAM83 Family Regulates MAPK Signaling in Human CancerMolecular Cancer Research, 2014
- Dedifferentiation and reprogramming: origins of cancer stem cellsEMBO Reports, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast CancersMolecular & Cellular Proteomics, 2013
- FAM83B mediates EGFR- and RAS-driven oncogenic transformationJournal of Clinical Investigation, 2012
- FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceJournal of Clinical Investigation, 2012
- CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line SetCancer Research, 2012
- CellMiner: a relational database and query tool for the NCI-60 cancer cell linesBMC Genomics, 2009
- FAM83H Mutations in Families with Autosomal-Dominant Hypocalcified Amelogenesis ImperfectaThe American Journal of Human Genetics, 2008